Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History $1.05 +0.01 (+0.96%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$1.06 +0.01 (+0.95%) As of 08/29/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enlivex Therapeutics Stock Price Performance The Enlivex Therapeutics (ENLV) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 19.23%, with a year-to-date return of -10.26%. In the past month, the stock has decreased 31.82%, reflecting recent market activity. As of the latest close, Enlivex Therapeutics traded at $1.05 with a market cap of $24.83 million and volume of 205,727 shares. Five years ago, the stock traded at $5.35, representing a 80.37% decrease over that period. At the time, it had a market cap of $68.48 million and a volume of 38,203 shares. Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.78%1 Month Performance-31.82%3 Month Performance+8.99%Year-To-Date Performance-10.26%1 Year Performance-19.23%5 Year Performance-80.37% ENLV Stock Chart for Saturday, August, 30, 2025 ENLV Chart by TradingView Enlivex Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/29/2025$1.04$1.05+0.96%$1.06$1.02205,727 shs$24.83 million08/28/2025$1.09$1.04-4.59%$1.10$1.03295,925 shs$24.60 million08/27/2025$1.08$1.09+0.93%$1.13$1.08438,147 shs$25.78 million08/26/2025$1.08$1.08$1.11$1.06380,050 shs$25.54 million08/25/2025$1.05$1.08+2.86%$1.12$1.05630,656 shs$25.54 million08/22/2025$1.03$1.05+1.94%$1.05$0.98887,884 shs$24.83 million08/21/2025$1.10$1.03-6.36%$1.12$1.01934,986 shs$24.36 million08/20/2025$1.05$1.10+4.76%$1.15$1.03878,547 shs$26.02 million08/19/2025$1.25$1.05-16.00%$1.24$1.022.91 million shs$24.83 million08/18/2025$1.82$1.25-31.32%$1.75$1.2210.43 million shs$29.56 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/15/2025$1.78$1.82+2.25%$2.10$1.762.24 million shs$43.04 million08/14/2025$1.56$1.78+14.10%$1.84$1.55922,024 shs$42.10 million08/13/2025$1.57$1.56-0.64%$1.78$1.501.03 million shs$36.90 million08/12/2025$1.47$1.57+6.80%$1.64$1.47504,142 shs$37.13 million08/11/2025$1.43$1.47+2.80%$1.58$1.43466,541 shs$34.77 million08/08/2025$1.35$1.43+5.93%$1.49$1.35245,292 shs$33.82 million08/07/2025$1.35$1.35$1.39$1.32199,624 shs$31.93 million08/06/2025$1.39$1.35-2.88%$1.40$1.31325,651 shs$31.93 million08/05/2025$1.48$1.39-6.08%$1.53$1.34523,499 shs$32.87 million08/04/2025$1.45$1.48+2.07%$1.66$1.47819,515 shs$35.00 million08/01/2025$1.49$1.45-2.68%$1.52$1.41250,283 shs$34.29 million07/31/2025$1.54$1.49-3.25%$1.60$1.48307,709 shs$35.24 million07/30/2025$1.42$1.54+8.45%$1.66$1.44996,051 shs$36.42 million07/29/2025$1.26$1.42+12.70%$1.44$1.28668,799 shs$33.58 million Related Companies ANIX Stock Chart SRZN Stock Chart CRDL Stock Chart XBIT Stock Chart VTGN Stock Chart VIRI Stock Chart IMUX Stock Chart ABOS Stock Chart EPIX Stock Chart CELU Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
